1 / 31

The University of Michigan Depression Center Colloquium Series

The University of Michigan Depression Center Colloquium Series. The Colloquium Series is made possible by an educational grant from GlaxoSmithKline. U-M Depression Center Colloquium Eating Disorders and Depression: Clinical Context. David S. Rosen, M.D., M.P.H

toyah
Download Presentation

The University of Michigan Depression Center Colloquium Series

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The University of Michigan Depression Center Colloquium Series The Colloquium Series is made possible by an educational grant from GlaxoSmithKline.

  2. U-M Depression Center ColloquiumEating Disorders and Depression:Clinical Context David S. Rosen, M.D., M.P.H University of Michigan Medical School Ann Arbor, Michigan, USA

  3. Spectrum of Eating Disorders Risk Factors Healthy Eater Typical Dieter Pathological Dieter ED-NOS ED Protective Factors

  4. Prevalence of Eating Disorders %

  5. Anorexia Nervosa: DSM-IV Diagnosis • Weight loss (or refusal to gain weight) below normal for age and height • Fear of fat, even though underweight • Body image distortion; or overconcern about weight or shape even though underweight • Amenorrhea (abnormal fxn of H-P-G axis)

  6. Anorexia Nervosa: Presentation • Nutritional deficiency and wasting • Delusion of being fat • Obsession to be thinner • Denial • High rates of medical complications • High rates of psychiatric co-morbidity

  7. Anorexia Nervosa: Epidemiology • Point prevalence < 1% • Lifetime prevalence: ~ 0.6-4.0% • Increasing prevalence in past 30 years • Females >> males • Typically presents in adolescence • Increasing presentation among “atypical” patients (e.g., males, children, people of color, immigrants, low SES) • Partial syndromes are common

  8. Bulimia Nervosa: DSM-IV Diagnosis • Binge eating; lack of control over binges • Abnormal compensatory behavior to manage weight • Overconcern with body weight or shape • Symptoms at least 2x/week for 3 mo

  9. Bulimia Nervosa: Presentation • Recurrent, secretive binge eating • Awareness that eating is abnormal • Fear of loss of control over eating • Short-term relief from compensatory behaviors • Depression, shame, guilt • Low, normal, or high weight • High rates of medical complications • High rates of psychiatric co-morbidity

  10. Bulimia Nervosa: Epidemiology • Point prevalence: ~ 0.4-3.0% • Lifetime prevalence: ~ 1-6% • Increasing prevalence in past 10 years • Females >>> males • Occurs primarily in older adolescents and young adults • Partial syndromes are common

  11. Spectrum of Eating Disorders Risk Factors Healthy Eater Typical Dieter Pathological Dieter ED-NOS ED Protective Factors

  12. Eating Disorders: Etiology Multifactorial Etiology: • Biologic risk factors • Individual/psychological risk factors • Familial risk factors • Sociocultural risk factors

  13. Etiology: Biologic Risk Factors • EDs aggregate within families with distinct and significant genetic effects • Genetic (and environmental) influences vary across adolescence and may be variably expressed at different stages of development • Consistent association of EDs with alteration in Serotonin function

  14. Etiology: Biologic Risk Factors • Native animal models of AN exist among swine, sheep, and goats: Genetically determined physiological response to excessive leanness; oversensitivity to stress • Animal models of binge eating have been developed in rats: Restriction/re-feeding cycles; response to stress; exposure to highly palatable food. • Binge eating appears to be motivated by reward rather than metabolic need

  15. Etiology: Heritable Risk • AN 11x more likely in female relatives of AN proband vs. relatives of controls • BN 4-5x more likely in female relatives of BN proband vs. relatives of controls • ~15% lifetime risk of ED in female relatives of AN or BN proband vs. 4% lifetime risk in relatives of controls Strober et al. Am J Psychiatry 2000; 157:393

  16. Etiology: Individual Characteristics • Perfectionism • Over-achieving • Obsessional thinking • Low self-esteem • Depression • ? History of sexual abuse

  17. Etiology: Sociocultural Pressure • Society’s focus on attractiveness • Prevailing cultural stereotypes • “Thin is beautiful” • Unhealthy media representationsof women • Emergence of “pro-Ana” and “pro-mia” influences

  18. Malnutrition • Decreased metabolic rate • Inability to maintain body temperature • Decrease in brain mass (? Reversible) • Cognitive changes • Affective symptoms • Medical sequelae of malnutrition are the leading cause of death in anorexia nervosa

  19. Medical Complications of EDs • Cardiovascular complications • Gastrointestinal complications • Fluid/electrolyte complications • Skeletal complications • Renal complications • Endocrine, hormonal,and reproductive complications • Skin and dental complications • Re-feeding syndrome

  20. Psychiatric Co-morbidity • Affective disorders, suicidality • Anxiety disorders • Obsessional behavior, OCD • Substance abuse • Suicide is the leading cause of deathin bulimia nervosa

  21. Anxiety Disorders and EDs • Methodologically rigorous controlled study of 271 women with AN and BN: • Lifetime co-morbidity with at least one anxiety d/o: ~ 70% (significantly > controls) • Most anxiety disorders persist after recovery • In approximately half of co-morbid cases, the anxiety disorder precedes the ED Godart NT et al. Psychiatr Res 2003; 117:245

  22. Depression and EDs • Longitudinal, community-based, “Children in the Community” study: • Depressive disorders are independent risk factors for the development of EDs (OR=8.45) and ED Sx. • Depressive disorders during early adolescence are associated with development of later EDs • EDs during adolescence associated with significantly increased risk of depressive (OR=4.32) and anxiety disorders (OR=4.13) during early adulthood. Johnson JG et al. J Consulting and Clin Psychol 2002; 5:1119Johnson JG et al. Arch Gen Psychiatry 2002; 59:545

  23. AN: State-of-the-Art Treatment • Few RCTs and little evidence. • Interdisciplinary treatment is considered to be the standard of care • Early nutritional rehabilitation is essential • CBT is the most useful psychotherapy • In adolescents, evidence strongly supports family-oriented treatment • Limited role for pharmacotherapy

  24. BN: State-of-the-Art Treatment • Self-help strategies are of limited value • BN-focused CBT is the most effective treatment but short-term outcomes are still poor (< 50%) • Pharmacotherapy (SSRIs, Topiramate) is a useful adjunct to CBT but is less effective as monotherapy or when combined with self-help • Early response to treatment is a useful predictor of both short- and long-term outcomes

  25. Prognosis: • Inadequate data; inadequate follow-up • Variable definitions of “recovery” and “cure” • Long-term outcomes are better than previously assumed • Significant ongoing risk of psychiatric illness • Relapse prevention is important! • Mortality is still significant

  26. Outcome of AN by Age at Onset and Duration of Follow-up Both younger age at onset, and longer duration of follow-up are associated with better outcomes. Adol Onset All Ages Steinhausen HC. Am J Psychiatr 2002; 159:1284

  27. Prognosis • At long-term follow-up, most adolescent patients with ED (~70%) have fully recovered and >80% have normal eating, weight, and menses. However, they will have spent more than 1/3 of their lives in treatment! • At long-term follow-up, approximately 10% of patients will have persistent AN, 20% will have BN, and 5% will have died. Steinhausen H-C et al. Eur Child & Adolesc Psych 2003; 12:91-98

  28. Outcome of Adolescent-Onset ED in a Longitudinal Cohort of Girls: • 982 adolescent girls from a school-based Australian cohort; 14-15 y/o at entry • Seven waves over six years • Point prevalence of ED 2.4% at age 15-18 • Point prevalence of ED 3% at age 20 • Prevalence of ED 8.8% across entire study • Only 11% of teens with ED still had ED at follow-up • However, nearly half had persistent depression and/or anxiety at follow-up Patton GC et al. Eur Child and Adol Psychiatr. 2003; 12 (Suppl 1):I25

  29. Summary • Eating disorders are common, even though AN and BN are uncommon • Biology and genetics are fundamental to the etiology of eating disorders • Medical complications of eating disorders may affect every organ system and can be serious or fatal. • Significant psychiatric co-morbidity

  30. Summary • Early treatment of adolescent ED may be associated with a better prognosis • With excellent treatment, it is reasonable to expect a good prognosis (but be prepared to work at it for a very long time). • More effective treatments for ED are urgently needed and may be informed by a better understanding of their biology

More Related